World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
163
Citations
95639
World Ranking
689
National Ranking
397

Michael Andreeff publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael Andreeff sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,533 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael Andreeff D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Andreeff sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 163 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael Andreeff is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the fields of medicine and biochemistry, genetics, and molecular biology, with a strong emphasis on hematology and molecular biology subfields. The scientist's work spans oncology, genetics, and cancer research, addressing various complex aspects of malignant diseases.

Their contributions are notably concentrated in areas such as acute myeloid leukemia, protein degradation and inhibitors, chronic myeloid leukemia treatments, multiple myeloma research and treatments, histone deacetylase inhibitors research, myeloproliferative neoplasms diagnosis and treatment, and chronic lymphocytic leukemia research.

Prominent recent publications include:

  • Bone marrow niches in haematological malignancies, 2020, Nature reviews. Cancer
  • MDM2 inhibition: an important step forward in cancer therapy, 2020, Leukemia
  • Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics, 2020, Nature Communications
  • Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia, 2021, Journal of Clinical Oncology
  • 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial, 2020, The Lancet Haematology

The scientist frequently collaborates with several researchers in the field, including:

  • Marina Konopleva
  • Courtney D. DiNardo
  • Elias Jabbour
  • Guillermo Garcia-Manero
  • Hagop M. Kantarjian

Among the journals where Michael Andreeff has published, the most frequent venues are Blood, Clinical Lymphoma Myeloma & Leukemia, Cancer Research, Leukemia, and Juntendo Medical Journal. These venues reflect a consistent focus on hematology, oncology, and related clinical research.

Best Publications

  • Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

    Raymond P. Warrell;Stanley R. Frankel;Wilson H. Miller;David A. Scheinberg

  • Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas

    Akira Nakamizo;Frank Marini;Toshiyuki Amano;Asadullah Khan

  • Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

    Michael J. Keating;Susan O'Brien;Maher Albitar;Susan Lerner

  • Bone Marrow-derived Mesenchymal Stem Cells as Vehicles for Interferon-β Delivery into Tumors

    Matus Studeny;Frank C. Marini;Richard E. Champlin;Claudia Zompetta

  • Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

    Marina Konopleva;Rooha Contractor;Twee Tsao;Ismael Samudio

  • Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

    Matus Studeny;Frank C. Marini;Jennifer L. Dembinski;Claudia Zompetta

  • MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

    Ramiro Garzon;Shujun Liu;Muller Fabbri;Zhongfa Liu

  • Flow Cytometry in Clinical Cancer Research

    Barthel Barlogie;Martin N. Raber;Johannes Schumann;Tod S. Johnson

  • Expression and Prognostic Significance of IAP-Family Genes in Human Cancers and Myeloid Leukemias

    Ingo Tamm;Steven M. Kornblau;Harry Segall;Stanislaw Krajewski

  • Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

    Erika L. Spaeth;Jennifer L. Dembinski;A Kate Sasser;Keri B. Watson

  • Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    Hagop M Kantarjian;Susan O'Brien;Terry L. Smith;Jorge E Cortes

  • Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

    Sergio Giralt;Peter F. Thall;Issa Khouri;Xuemei Wang

  • MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

    Ramiro Garzon;Stefano Volinia;Stefano Volinia;Chang-Gong Liu;Cecilia Fernandez-Cymering

  • Cancer stem cell definitions and terminology: the devil is in the details

    Peter Valent;Dominique Bonnet;Ruggero De Maria;Tsvee Lapidot

  • Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

    Raoul Tibes;Yi Hua Qiu;Yiling Lu;Bryan Hennessy

  • Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.

    Shannon Kidd;Erika Spaeth;Jennifer L. Dembinski;Martin Dietrich

  • Convention on nomenclature for DNA cytometry

    Wolfgang Hiddemann;Johannes Schumann;Michael Andreeff;Barthel Barlogie

  • Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

    Ismael Samudio;Romain Harmancey;Michael Fiegl;Hagop Kantarjian

  • Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

    Deborah A. Thomas;Stefan Faderl;Jorge Cortes;Susan O'Brien

  • Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells

    E. Spaeth;Ann H Klopp;J. Dembinski;Michael Andreeff

Frequent Co-Authors

Marina Konopleva
Marina Konopleva The University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Steven M. Kornblau
Steven M. Kornblau The University of Texas MD Anderson Cancer Center
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center
Naval Daver
Naval Daver The University of Texas MD Anderson Cancer Center
Elias Jabbour
Elias Jabbour The University of Texas MD Anderson Cancer Center
Sherry Pierce
Sherry Pierce The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible study options or alternative career paths, there are many online degrees to consider. One popular choice is becoming a psychiatric nurse practitioner. There are psych np programs available online, letting you specialize in mental health treatment while balancing work or family commitments.

If you’re more interested in healthcare operations and leadership, a health administration degree online can train you in management skills needed to run clinics, hospitals, and health organizations. For those looking to upskill further, pursuing a postgraduate business-focused qualification is an option. Learn about masters in healthcare administration cost to find affordable ways to advance your career.

Advanced practice nurses may want to consider a Doctor of Nursing Practice. There are cheap dnp online programs for those seeking to reach the highest levels of clinical expertise and leadership in healthcare without overwhelming tuition costs.

Best Scientists Citing Michael Andreeff

Trending Scientists

Recently Published Articles